Conventional markers in determination of activity of sarcoidosis

International Immunopharmacology

Volumn 25, Issue 1, 2015, Pages 174-179

  Gungor, Sinem ^a   Ozseker, Ferhan ^a   Yalcinsoy, Murat ^a   Akkaya, Esen ^a   Can, Günay ^b   Eroglu, Hacer ^c   Genc, Nilgün Sema ^d  

^a Sureyyapasa Chest Diseases and Chest Surgery Training Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase (ADA); Angiotensin converting enzyme (ACE); Sarcoidosis; Sarcoidosis activity; Serum amyloid A (SAA); Soluble interleukin 2 receptor (sIL2R)

Indexed keywords

ADENOSINE DEAMINASE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN E; SERUM AMYLOID A; SOLUBLE INTERLEUKIN 2 RECEPTOR; BIOLOGICAL MARKER; INTERLEUKIN 2 RECEPTOR; SERUM AMYLOID P;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; EXTRAPULMONARY SARCOIDOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; DISEASE COURSE; METABOLISM; MIDDLE AGED; PHYSIOLOGIC MONITORING; PREDICTIVE VALUE; PROGNOSIS; SARCOIDOSIS;

ADENOSINE DEAMINASE; ADULT; BIOMARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PEPTIDYL-DIPEPTIDASE A; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, INTERLEUKIN-2; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID P-COMPONENT;

EID: 84922523790     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.01.015     Document Type: Article

References (33)

1. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 1994; 7:624-627.
2. T. Çaʇatay, S. Bilir, H. Yanardaʇ, Z. Gülbaran, and Ç. Papila Pulmoner sarkoidozlu olgularda immünglobulin ve kompleman düzeylerinin hastaliʇin aktivasyonuyla ilişkisi Solunum Hastaliklari 10 1999 254 258
3. A. Planck, A. Eklund, and J. Grunewald Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients Eur Respir J 21 2003 52 57
4. J.S. Johansen, N. Milman, M. Hansen, C. Garbarsch, P.A. Price, and N. Graudal Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity? Respir Med 99 4 2005 Apr 396 402
5. R. Kieszko, P. Krawczyk, O. Jankowska, S. Chocholska, A. Krol, and J. Milanowski The clinical significance of interleukin 18 assessment in sarcoidosis patients Respir Med 101 2007 722 728
6. S. Rothkrantz-Kos, M.P. Dieijen-Vesser, P.G.H. Mulder, and M. Drent Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis Clinical Chemistry 49 9 2003 1510 1517
7. J. Müller-Quernheim Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology Sarcoidosis Vasc Diffuse Lung Dis 15 1998 22 37
8. J. Müller-Quernheim Sarcoidosis: clinical manifestations, staging and therapy Respir Med 92 1998 140 149
9. G.W. Hunninghake, J.D. Fulmer, R.C. Young, J.E. Gadek, and R.G. Crystal Localization of the immune response in sarcoidosis Am Rev Respir Dis 120 7 1979 Jul 49 57
10. T. Yamada Serum amyloid A (SAA): a concise review of biology, an assay methods and clinical usefulness Clin Chem Lab Med 37 1999 381 388
11. J.C. Grutters, J.M. Fellrath, L. Mulder, R. Janssen, J.M.M. Bosch, and H. Velzen-Blad Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis Chest 124 2003 186 195
12. M. Rust, L. Bergmann, T. Kühn, S. Tuengerthal, K. Bartmann, and P.S. Mitrou Prognostic value of chest radiograph, serum ACE, T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis Respiration 48 3 1985 231 236
13. J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, and J.A. Wedzicha Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586
14. The American Thoracic Society (ATS), The European Respiratory Society (ERS) and World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.
15. M.A. Judson An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment Chest 115 4 1999 Apr 115 165
16. The American Thoracic Society (ATS), The European Respiratory Society (ERS) and World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.
17. L.T. Tanoue, and J.A. Elias Systemic sarcoidosis G.L. Baum, J.D. Crapo, B.R. Celi, J.B. Karlinsky, editors. Textbook of pulmonary disease 6th ed. 1998 Lippincott-Raven Publishers Philadelphia 407 430
18. U. Costabel Consensus conference: activity of sarcoidosis. Third WASOG meeting. Los Angeles, USA, September 8-11, 1993 Eur Respir J 7 1994 624 627
19. D. Valeyre, H. Nunes, Y. Uzunhan, P.Y. Brillet, and J. Müller-Quernheim Lancet 383 2014 1155 1167
20. Kadowaki T, Hamada H, Hamaguchi N, Sakai K, Ito R, Higaki J. Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-60 in serum as diagnostic markers in pulmonary sarcoidosis. Abstracts 17th ERS Annual Congress, Stockholm, Sweden, September 15-19, 2007.
21. T. Yagura, M. Shimizu, Y. Yamamura, and T. Tachibana Serum IgE levels and reaginic type skin reactions in sarcoidosis Clin Exp Immunol 21 2 1975 289 297
22. S. Miyoshi, H. Homada, T. Kadowaki, N. Hamaguchi, R. Ito, K. Irifune, et al. Chest 137 6 2010 1391 1397
23. S. Arslan, O. Çelik, A. Baran, S. Güngör, and E. Akkaya Sarkoidozda aktivite belirlemede serum belirtec¸lerinin önemi Ege TIp Dergisi 49 1 2010 41 48
24. F.C. De Beer, E.A. Fagan, G.R.V. Hughes, R.K. Mallya, J.G. Lanham, and M.B. Pepys Serum amyloid A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis Lancet 231-3 1982
25. A. Salazar, J. Maña, C. Fiol, I. Hurtado, J.M. Argimon, R. Pujol, et al. Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis Atherosclerosis 152 2 2000 Oct 497 502
26. Y. Zhang, X. Chen, Y. Hu, S. Du, L. Shen, Y. He, et al. Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients Respiratory Research 14 2013 18
27. F. Ozseker, S. Buyukozturk, B. Depboylu, D. Yilmazbayhan, E. Karayigit, A. Gelincik, et al. Serum amyloid A (SAA) in induced sputum of asthmatics: a new look to an old marker Int Immunopharmacol 6 10 2006 Oct 1569 1576
28. M. Drent, R.M. Wirnsberger, S. Vries, M.P. Von Dieijen-Visser, E.F. Wouters, and A.M. Schols Association of fatigue with an acute phase response in sarcoidosis Eur Respir J 13 1999 718 722
29. Hattori T, Konno S, Shigemura M, Matsuno K, Shimizu C, Shigehara K, et al. Total serum IgE levels and atopic status in patients with sarcoidosis. Allergy Asthma Proc. 2012 Jan-Feb;33(1):90-4.
30. M. Kubota, M. Katagiri, and T. Imasaki Adenosine deaminase activity in bronchoalveolar lavage fluid of sarcoidosis patients Nihon Kokyuki Gakkai Zasshi 37 5 1999 374 379
31. C. Albera, I. Mabritto, and P. Ghio Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis Sarcoidosis 1081 1993 18 25
32. T. Fukami, E. Miyazaki, T. Matsumoto, T. Kumamoto, and T. Truda Elevated expression of interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis Cytokine 30 2005 203 211
33. J. Müller-Quernheim Sarcoidosis: immunopathogenetic concept and their clinical application Eur Respir J 12 1998 716 738